Didier A. Depireux
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Didier A. Depireux has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- Ronna Hertzano
Neurotology Branch, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, USA
4 shared publications - Beatrice Milon
Department of Otorhinolaryngology Head and Neck Surgery, University of Maryland School of Medicine, Baltimore, MD 21201, USA
3 shared publications - Jessica A. Mong
Department of Pharmacology and Physiology, University of Maryland, School of Medicine , Baltimore, MD
2 shared publications Adam T. Palermo
Decibel Therapeutics, Boston, MA 02215, USA
1 shared publication- Ahmed Mahmood Mohammed
College of Electrical Engineering, University of Technology
1 shared publication - Andrew Broda
Anne Arundel Med Ctr, Annapolis, MD USA
1 shared publication
Latest Publications
- Open Access
- 28 April 2026
- Published by SAGE Publications in Ear, Nose & Throat Journal
Feasibility Assessment of Noninvasive Vestibular System Masking for Recalcitrant Pediatric Vertigo Management
Objective: In pediatric populations, untreated vertigo can be detrimental to overall health and quality of life. Current therapies for vestibular dysfunction include medical management and vestibular physical therapy. Noninvasive alternatives, such as vestibular stimulation, are gaining more attention. For this investigation, we trialed a novel study device utilizing noninvasive vestibular system masking (nVSM), which imparts low-frequency vibrations to the skull to alleviate common symptoms. In this pilot case series, we sought to determine the impact induced by this device as a treatment option. Methods: Prospective pilot study at a tertiary, stand-alone children’s hospital. Adolescents with persistent vertigo were tested in a computerized dynamic posturography (CDP) machine, which created real-world simulations to induce dizziness. CDP was completed twice during the testing appointment: once without the nVSM for a baseline level and then with the device. Symptom severity was assessed via the Pediatric Vestibular Symptom Questionnaire (PVSQ). Results: Five female patients with a mean age of 15.6 years were recruited into the trial. We observed a trend that might suggest differential responses across patient types, though a small sample size precludes any definitive conclusions. Mean PVSQ scores in the pre- and posttesting periods demonstrated decreased symptom severity (2.02-1.32). Although 2 participants reported slightly worsened scores, most expressed enthusiasm for continued access to the device. Conclusion: In this uncontrolled pilot study, patients reported symptom reductions while using the device; however, controlled studies are needed to distinguish therapeutic effects from placebo responses. The device was well tolerated and may function as a low-risk, noninvasive alternative to current therapies. Future work will continue to evaluate the device’s effectiveness. In this pilot study, for patients with no other options, the nVSM based on low-frequency inner ear stimulation has the potential to serve as a valuable and immediate treatment for symptom relief.
- 28 April 2026
- Published by SAGE Publications in Ear, Nose & Throat Journal
Open AccessFeasibility Assessment of Noninvasive Vestibular System Masking for Recalcitrant Pediatric Vertigo Management
Objective: In pediatric populations, untreated vertigo can be detrimental to overall health and quality of life. Current therapies for vestibular dysfunction include medical management and vestibular physical therapy. Noninvasive alternatives, such as vestibular stimulation, are gaining more attention. For this investigation, we trialed a novel study device utilizing noninvasive vestibular system masking (nVSM), which imparts low-frequency vibrations to the skull to alleviate common symptoms. In this pilot case series, we sought to determine the impact induced by this device as a treatment option. Methods: Prospective pilot study at a tertiary, stand-alone children’s hospital. Adolescents with persistent vertigo were tested in a computerized dynamic posturography (CDP) machine, which created real-world simulations to induce dizziness. CDP was completed twice during the testing appointment: once without the nVSM for a baseline level and then with the device. Symptom severity was assessed via the Pediatric Vestibular Symptom Questionnaire (PVSQ). Results: Five female patients with a mean age of 15.6 years were recruited into the trial. We observed a trend that might suggest differential responses across patient types, though a small sample size precludes any definitive conclusions. Mean PVSQ scores in the pre- and posttesting periods demonstrated decreased symptom severity (2.02-1.32). Although 2 participants reported slightly worsened scores, most expressed enthusiasm for continued access to the device. Conclusion: In this uncontrolled pilot study, patients reported symptom reductions while using the device; however, controlled studies are needed to distinguish therapeutic effects from placebo responses. The device was well tolerated and may function as a low-risk, noninvasive alternative to current therapies. Future work will continue to evaluate the device’s effectiveness. In this pilot study, for patients with no other options, the nVSM based on low-frequency inner ear stimulation has the potential to serve as a valuable and immediate treatment for symptom relief.
- Open Access
- 11 November 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (22) , 12208
Estradiol Protects against Noise-Induced Hearing Loss and Modulates Auditory Physiology in Female Mice
Recent studies have identified sex-differences in auditory physiology and in the susceptibility to noise-induced hearing loss (NIHL). We hypothesize that 17β-estradiol (E2), a known modulator of auditory physiology, may underpin sex-differences in the response to noise trauma. Here, we gonadectomized B6CBAF1/J mice and used a combination of electrophysiological and histological techniques to study the effects of estrogen replacement on peripheral auditory physiology in the absence of noise exposure and on protection from NIHL. Functional analysis of auditory physiology in gonadectomized female mice revealed that E2-treatment modulated the peripheral response to sound in the absence of changes to the endocochlear potential compared to vehicle-treatment. E2-replacement in gonadectomized female mice protected against hearing loss following permanent threshold shift (PTS)- and temporary threshold shift (TTS)-inducing noise exposures. Histological analysis of the cochlear tissue revealed that E2-replacement mitigated outer hair cell loss and cochlear synaptopathy following noise exposure compared to vehicle-treatment. Lastly, using fluorescent in situ hybridization, we demonstrate co-localization of estrogen receptor-2 with type-1C, high threshold spiral ganglion neurons, suggesting that the observed protection from cochlear synaptopathy may occur through E2-mediated preservation of these neurons. Taken together, these data indicate the estrogen signaling pathways may be harnessed for the prevention and treatment of NIHL.
- 11 November 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (22) , 12208
Open AccessEstradiol Protects against Noise-Induced Hearing Loss and Modulates Auditory Physiology in Female Mice
Recent studies have identified sex-differences in auditory physiology and in the susceptibility to noise-induced hearing loss (NIHL). We hypothesize that 17β-estradiol (E2), a known modulator of auditory physiology, may underpin sex-differences in the response to noise trauma. Here, we gonadectomized B6CBAF1/J mice and used a combination of electrophysiological and histological techniques to study the effects of estrogen replacement on peripheral auditory physiology in the absence of noise exposure and on protection from NIHL. Functional analysis of auditory physiology in gonadectomized female mice revealed that E2-treatment modulated the peripheral response to sound in the absence of changes to the endocochlear potential compared to vehicle-treatment. E2-replacement in gonadectomized female mice protected against hearing loss following permanent threshold shift (PTS)- and temporary threshold shift (TTS)-inducing noise exposures. Histological analysis of the cochlear tissue revealed that E2-replacement mitigated outer hair cell loss and cochlear synaptopathy following noise exposure compared to vehicle-treatment. Lastly, using fluorescent in situ hybridization, we demonstrate co-localization of estrogen receptor-2 with type-1C, high threshold spiral ganglion neurons, suggesting that the observed protection from cochlear synaptopathy may occur through E2-mediated preservation of these neurons. Taken together, these data indicate the estrogen signaling pathways may be harnessed for the prevention and treatment of NIHL.
- Top Cited PapersOpen Access
- 1 September 2021
- Published by Elsevier in Cell Reports
- Vol. 36 (13) , 109758
A cell-type-specific atlas of the inner ear transcriptional response to acoustic trauma
- 1 September 2021
- Published by Elsevier in Cell Reports
- Vol. 36 (13) , 109758
Top Cited PapersOpen AccessA cell-type-specific atlas of the inner ear transcriptional response to acoustic trauma
- 1 August 2020
- Published by Elsevier in Otolaryngologic Clinics of North America
- Vol. 53 (4) , XVII-XVIII
Tinnitus: Clinical, Basic Science, Audiologic and Industry Updates
- 1 August 2020
- Published by Elsevier in Otolaryngologic Clinics of North America
- Vol. 53 (4) , XVII-XVIII
Tinnitus: Clinical, Basic Science, Audiologic and Industry Updates
- 1 August 2020
- Published by Elsevier in Otolaryngologic Clinics of North America
- Vol. 53 (4) , 531-542
Noise
- 1 August 2020
- Published by Elsevier in Otolaryngologic Clinics of North America
- Vol. 53 (4) , 531-542
Noise
- 1 March 2019
- Published by Elsevier in Journal of Magnetism and Magnetic Materials
- Vol. 474, 187-198
On-chip testing of the speed of magnetic nano- and micro-particles under a calibrated magnetic gradient
- 1 March 2019
- Published by Elsevier in Journal of Magnetism and Magnetic Materials
- Vol. 474, 187-198
On-chip testing of the speed of magnetic nano- and micro-particles under a calibrated magnetic gradient
- Open Access
- 12 March 2018
- Published by Springer Nature in Biology of Sex Differences
- Vol. 9 (1) , 1-14
The impact of biological sex on the response to noise and otoprotective therapies against acoustic injury in mice
Noise-induced hearing loss (NIHL) is the most prevalent form of acquired hearing loss and affects about 40 million US adults. Among the suggested therapeutics tested in rodents, suberoylanilide hydroxamic acid (SAHA) has been shown to be otoprotective from NIHL; however, these results were limited to male mice. Here we tested the effect of SAHA on the hearing of 10-week-old B6CBAF1/J mice of both sexes, which were exposed to 2 h of octave-band noise (101 dB SPL centered at 11.3 kHz). Hearing was assessed by measuring auditory brainstem responses (ABR) at 8, 16, 24, and 32 kHz, 1 week before, as well as at 24 h and 15–21 days following exposure (baseline, compound threshold shift (CTS) and permanent threshold shift (PTS), respectively), followed by histologic analyses. We found significant differences in the CTS and PTS of the control (vehicle injected) mice to noise, where females had a significantly smaller CTS at 16 and 24 kHz (p < 0.0001) and PTS at 16, 24, and 32 kHz (16 and 24 kHz p < 0.001, 32 kHz p < 0.01). This sexual dimorphic effect could not be explained by a differential loss of sensory cells or synapses but was reflected in the amplitude and amplitude progression of wave I of the ABR, which correlates with outer hair cell (OHC) function. Finally, the frequency of the protective effect of SAHA differed significantly between males (PTS, 24 kHz, p = 0.002) and females (PTS, 16 kHz, p = 0.003), and the magnitude of the protection was smaller in females than in males. Importantly, the magnitude of the protection by SAHA was smaller than the effect of sex as a biological factor in the vehicle-injected mice. These results indicate that female mice are significantly protected from NIHL in comparison to males and that therapeutics for NIHL may have a different effect in males and females. The data highlight the importance of analyzing NIHL experiments from males and females, separately. Finally, these data also raise the possibility of effectors in the estrogen signaling pathway as novel therapeutics for NIHL.
- 12 March 2018
- Published by Springer Nature in Biology of Sex Differences
- Vol. 9 (1) , 1-14
Open AccessThe impact of biological sex on the response to noise and otoprotective therapies against acoustic injury in mice
Noise-induced hearing loss (NIHL) is the most prevalent form of acquired hearing loss and affects about 40 million US adults. Among the suggested therapeutics tested in rodents, suberoylanilide hydroxamic acid (SAHA) has been shown to be otoprotective from NIHL; however, these results were limited to male mice. Here we tested the effect of SAHA on the hearing of 10-week-old B6CBAF1/J mice of both sexes, which were exposed to 2 h of octave-band noise (101 dB SPL centered at 11.3 kHz). Hearing was assessed by measuring auditory brainstem responses (ABR) at 8, 16, 24, and 32 kHz, 1 week before, as well as at 24 h and 15–21 days following exposure (baseline, compound threshold shift (CTS) and permanent threshold shift (PTS), respectively), followed by histologic analyses. We found significant differences in the CTS and PTS of the control (vehicle injected) mice to noise, where females had a significantly smaller CTS at 16 and 24 kHz (p < 0.0001) and PTS at 16, 24, and 32 kHz (16 and 24 kHz p < 0.001, 32 kHz p < 0.01). This sexual dimorphic effect could not be explained by a differential loss of sensory cells or synapses but was reflected in the amplitude and amplitude progression of wave I of the ABR, which correlates with outer hair cell (OHC) function. Finally, the frequency of the protective effect of SAHA differed significantly between males (PTS, 24 kHz, p = 0.002) and females (PTS, 16 kHz, p = 0.003), and the magnitude of the protection was smaller in females than in males. Importantly, the magnitude of the protection by SAHA was smaller than the effect of sex as a biological factor in the vehicle-injected mice. These results indicate that female mice are significantly protected from NIHL in comparison to males and that therapeutics for NIHL may have a different effect in males and females. The data highlight the importance of analyzing NIHL experiments from males and females, separately. Finally, these data also raise the possibility of effectors in the estrogen signaling pathway as novel therapeutics for NIHL.
- 1 January 2010
- Published by Elsevier in Neuroscience
- Vol. 165 (2) , 612-620
Nonlinearity of coding in primary auditory cortex of the awake ferret
- 1 January 2010
- Published by Elsevier in Neuroscience
- Vol. 165 (2) , 612-620
Nonlinearity of coding in primary auditory cortex of the awake ferret
- 31 October 2009
- Published by Elsevier in Hearing Research
- Vol. 256 (1-2) , 11-20
Discrimination of auditory gratings in birds
- 31 October 2009
- Published by Elsevier in Hearing Research
- Vol. 256 (1-2) , 11-20
Discrimination of auditory gratings in birds
- 31 October 2009
- Published by Elsevier in Hearing Research
- Vol. 256 (1-2) , 118-130
Dynamics of spectro-temporal tuning in primary auditory cortex of the awake ferret
- 31 October 2009
- Published by Elsevier in Hearing Research
- Vol. 256 (1-2) , 118-130
Dynamics of spectro-temporal tuning in primary auditory cortex of the awake ferret